Ademola Oladipo
Overview
Explore the profile of Ademola Oladipo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sodeke O, Milligan K, Ezeuko I, Oladipo A, Emeh A, Bashorun A, et al.
AIDS
. 2024 Jun;
38(11):1714-1719.
PMID: 38870005
Background: To inform optimal management of HIV viremia on tenofovir, lamivudine, and dolutegravir (TLD), we examined viral load (VL) outcomes of a large cohort of adult PWH on TLD in...
2.
Lavoie M, Ehoche A, Blanco N, El-Imam I, Oladipo A, Dalhatu I, et al.
PLoS One
. 2023 Aug;
18(8):e0284847.
PMID: 37607206
Background: In Nigeria, results from the pilot of the Test and Treat strategy showed higher loss to follow up (LTFU) among people living with HIV compared to before its implementation....
3.
Dalhatu I, Aniekwe C, Bashorun A, Abdulkadir A, Dirlikov E, Ohakanu S, et al.
Methods Inf Med
. 2023 May;
62(3-04):130-139.
PMID: 37247622
Background: Timely and reliable data are crucial for clinical, epidemiologic, and program management decision making. Electronic health information systems provide platforms for managing large longitudinal patient records. Nigeria implemented the...
4.
Chun H, Abutu A, Milligan K, Ehoche A, Shiraishi R, Odafe S, et al.
Lancet Glob Health
. 2022 Nov;
10(12):e1815-e1824.
PMID: 36400087
Background: HIV transmission can occur with a viral load of at least 200 copies per mL of blood and low-level viraemia can lead to virological failure; the threshold level at...
5.
Jahun I, Said I, El-Imam I, Ehoche A, Dalhatu I, Yakubu A, et al.
PLoS One
. 2021 Sep;
16(9):e0257476.
PMID: 34543306
Background: Ineffective linkage to care (LTC) is a known challenge for community HIV testing. To overcome this challenge, a robust linkage to care strategy was adopted by the 2018 Nigeria...
6.
Boyd A, Jahun I, Dirlikov E, Greby S, Odafe S, Abdulkadir A, et al.
AIDS Res Ther
. 2021 Sep;
18(1):62.
PMID: 34538268
Background: To accelerate progress toward the UNAIDS 90-90-90 targets, US Centers for Disease Control and Prevention Nigeria country office (CDC Nigeria) initiated an Antiretroviral Treatment (ART) Surge in 2019 to...
7.
Dirlikov E, Jahun I, Odafe S, Obinna O, Onyenuobi C, Ifunanya M, et al.
MMWR Morb Mortal Wkly Rep
. 2021 Mar;
70(12):421-426.
PMID: 33764965
In 2018, an estimated 1.8 million persons living in Nigeria had HIV infection (1.3% of the total population), including 1.1 million (64%) who were receiving antiretroviral therapy (ART) (1). Effective...
8.
Stafford K, Odafe S, Lo J, Ibrahim R, Ehoche A, Niyang M, et al.
PLoS One
. 2019 Jul;
14(7):e0218555.
PMID: 31291273
In December 2016, the Nigerian Federal Ministry of Health updated its HIV guidelines to a Treat All approach, expanding antiretroviral therapy (ART) eligibility to all individuals with HIV infection, regardless...